Monday, November 17, 2014

22-month-old baby dies from ehrlichiosis

Nashville Jury Awards $5 Million In Death From Tick Infection

Posted: Oct 13, 2014 7:40 AM PDTUpdated: Oct 14, 2014 6:41 AM PDT

A local pediatric clinic and hospital were found jointly responsible for failure to diagnose the bacterial infection that led to the death of a young boy.

Nashville, TN, United States – - October 13, 2014 —

On October 2, 2014, a Nashville jury held a pediatric clinic and local hospital accountable for the wrongful death of 22-month-old Ryder Laurent. Ryder died on June 10, 2009, as a result of complications from ehrlichiosis, a tick-borne illness.

The jury ruled in favor of the Laurent family against Old Harding Pediatric Associates, which was found to be 50 percent responsible for Ryder's death. Vanderbilt University Medical Center was also found 50 percent responsible, but had resolved all issues associated with the case prior to trial.

"We are very pleased that the jury carefully listened to this tragic matter and rendered a verdict that was fair and just," said Ms. Laurent's attorney, Daniel Clayton, of Kinnard, Clayton & Beveridge in Nashville.

"Ms. Laurent did everything she could to get help for her son. The medical community let her down."

Ehrlichiosis is a bacterial infection transmitted by ticks. The disease causes flu-like symptoms in those infected and, as in the case of Ryder Laurent, can be fatal if it remains untreated.

According to the Centers for Disease Control (CDC), the antibiotic doxycycline is the first line treatment for ehrlichiosis. If it is administered within the first four to five days of symptoms, fever usually subsides within 24 to 72 hours and the infection is cured with no long-term problems.

In this case, the diagnosis and treatment both came too late for one little boy.

In May 2009, a tick bit Ryder Laurent while he was playing outside. Approximately two weeks later, he developed a fever and a rash on his face. Ryder's mother, Story Laurent, took her son to Old Harding Pediatric Associates in Nashville on Wednesday, June 3, because of his symptoms.

The pediatrician, Dr. Chris Patton, noted the recent tick bite on Ryder's chart, but advised Ms. Laurent that the bite had nothing do with her son's illness, citing an ear infection as the cause.

The following morning, the rash had spread all over Ryder's body. Ms. Laurent said that he had a high fever throughout the night, was experiencing episodes of disorientation and was patting his head like he had a headache.

She took Ryder back to Old Harding and saw Dr. James Keffer. Dr. Keffer failed to look at the chart from the day before, which would have revealed the recent tick bite, and diagnosed Ryder with an allergic reaction.

By Friday, with her child's symptoms worsening, Ms. Laurent took Ryder to Vanderbilt University Medical Center twice – once in the morning and once around midnight – and was sent home both times.

Finally on Monday, June 8, Ms. Laurent brought her son back to Vanderbilt, where an infectious disease expert made the presumptive diagnosis of ehrlichiosis. At that point treatment began, but it was too late.

Ryder Laurent died after suffering a brain herniation caused by ehrlichia meningitis on June 10, 2009. Ms. Laurent made the decision to give the gift of life and donated Ryder's organs.

For more information about us, please visit http://www.kinnardclaytonandbeveridge.com/Medical-Malpractice/

Contact Info:
Name: Daniel Clayton
Email: daniel@kcbattys.com
Organization: Kinnard, Clayton & Beveridge

Release ID: 65912

Discoverer of Lyme bacterium is in hospice

Dear Friends,
 
You may not be aware of this gentle and brilliant soul who identified the spirochete as the cause of Lyme disease. Thus it was named Borrelia.burgdorferi (Bb)

 
You may have heard that Willy Burgdorfer, discoverer of the Lyme spirochete, is in Hospice.

He is still aware of his surroundings but his health has been deteriorating all summer. We don't know how long he will live, but we have an opportunity to show our appreciation of his work. We hope that hearing from you will boost his spirits.

We have set up a website where you can express your thoughts to Willy about his life's work. We will share your words with his family. 
Please visit:

to send Willy a message.

Saturday, November 15, 2014

Interacttive Lyme disease map

 I am pleased to let you know that there is now an online interactive map displaying the prevalence of Lyme disease vectors In different geographical regions within California. 


Look under the heading Interactive Maps.

Tuesday, November 11, 2014

The Mayday Project Responds to Dr. Paul Auwaerter's Defense of IDSA Guidelines for Lyme Disease

Washington, DC
November 07, 2014
http://www.webwire.com/ViewPressRel.asp?aId=192558

The Mayday Project welcomes the response by Dr. Paul Auwaerter to our concerns about the IDSA guidelines for diagnosis and treatment of Lyme disease, which were discussed in a recent Medscape article about Mayday's outreach to IDSA members at the IDWeek medical conference in October 2014.

Dr. Auwaerter's statement that there can be "productive collaboration among advocacy groups" was especially encouraging.

Mayday also appreciates the open-mindedness of the doctors and researchers who spoke with us at IDWeek, and those who read our open letter to IDSA members (http://tinyurl.com/IDSAletter). We gained valuable insight into the complications of battling emerging diseases, such as Lyme, and a better understanding about the dangers related to overuse of antibiotics.

Monday, November 10, 2014

High-fat diet postpones brain aging in mice

November 6, 2014


Kerala coconuts (credit: Dan Iserman CC)
A new Danish-led research suggests that signs of brain aging can be postponed in mice if they are placed on a high-fat diet. The finding may one day allow for developing treatments for children suffering from premature aging and patients with Alzheimer's and Parkinson's disease.

Sunday, November 9, 2014

Lyme is the most misunderstood disease since AIDS

 

Sat Nov 8, 2014

Valley View: Lyme is the most misunderstood disease since AIDS
Gov. Andrew Cuomo should sign the Patients' Rights/Doctor Protection bill.
Holly Ahern, for The Poughkeepsie Journal (opinion page), Poughkeepsie, New York

With the possible exception of HIV/AIDS, no infectious disease in recent history has been as misunderstood, maligned or politicized as Lyme disease.

After more than two decades of controversy and government neglect, Lyme disease has become too large an issue to ignore any longer. A year ago, the Centers for Disease Control and Prevention reported that only 1 in 10 cases of Lyme disease were properly reported to public health agencies and increased the likely incidence to more than 300,000 new cases of Lyme disease in the U.S. per year. As a highly endemic state, a significant proportion of those cases are in New York.

Read the complete article:
http://tinyurl.com/mc6euzkhttp://tinyurl.com/mc6euzk

Letters:letterstoeditor@poughkeepsiejournal.com
or http://tinyurl.com/nbma5g3http://tinyurl.com/nbma5g3
The mission of LymeInfo is to keep you informed of issues that might be of interest to Lyme disease patients.   Postings are not meant to imply that we agree with the content of all items we distribute.

For Lyme information, see:
http://www.LymeInfo.net

A possible alternative to antibiotics

Credit: Eric Erbe, Christopher Pooley, Wikipedia
Nov 04, 2014
Scientists from the University of Bern have developed a novel substance for the treatment of severe bacterial infections without antibiotics, which would prevent the development of antibiotic resistance.
Ever since the development of penicillin almost 90 years ago, antibiotics have remained the gold standard in the treatment of bacterial infections. However, the WHO has repeatedly warned of a growing emergence of bacteria that develop . Once antibiotics do no longer protect from , a mere pneumonia might be fatal.

Alternative therapeutic concepts which lead to the elimination of bacteria, but do not promote resistance are still lacking.

A team of international scientists has tested a novel substance, which has been developed by Eduard Babiychuk and Annette Draeger from the Institute of Anatomy, University of Bern in Switzerland. This compound constitutes a novel approach for the treatment of bacterial infections: the scientists engineered artificial nanoparticles made of lipids, "" that closely resemble the membrane of host cells. These liposomes act as decoys for bacterial toxins and so are able to sequester and neutralize them. Without toxins, the bacteria are rendered defenseless and can be eliminated by the cells of the host's own immune system. The study will be published in Nature Biotechnology Nov 2.

Artificial bait for bacterial toxins

In clinical medicine, liposomes are used to deliver specific medication into the body of patients. Here, the Bernese scientists have created liposomes which attract bacterial toxins and so protect host cells from a dangerous toxin attack.

"We have made an irresistible bait for . The toxins are fatally attracted to the liposomes, and once they are attached, they can be eliminated easily without danger for the host cells", says Eduard Babiychuk who directed the study.

"Since the bacteria are not targeted directly, the liposomes do not promote the development of ", adds Annette Draeger. Mice which were treated with the liposomes after experimental, fatal septicemia survived without additional antibiotic therapy.